PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, University Hospital Complex of Vigo, IRIDIS (Investigation in Rheumatology and Immune-Mediated Diseases) Group, Galicia Sur Health Research Institute, SERGAS-UVIGO, Vigo, Spain.\', \'Department of Pharmacy, University Hospital Complex of Vigo, Vigo, Spain.\', \'Department of Pharmacy, University Hospital Complex of Vigo. NeumoVigo I+i Research Group. Sur Health Research Institute. SERGAS-UVIGO, Vigo, Spain.\', \'Methodology and Statistics Unit, Galicia Sur Health Research Institute (IIS Galicia Sur, SERGAS-UVIGO, Vigo, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/jcpt.13337
?:hasPublicationType
?:journal
  • Journal of clinical pharmacy and therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 33368439
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.722
?:rankingScore_hIndex
  • 61
is ?:relation_isRelatedTo_publication of
?:title
  • Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33368439>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33368439>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all